Skip to main content
. Author manuscript; available in PMC: 2012 Jan 17.
Published in final edited form as: Pediatr Crit Care Med. 2009 Jul;10(4):431–438. doi: 10.1097/PCC.0b013e318198bd13

Figure 2.

Figure 2

Total study sample size required for 90% power (using a two-sided chi-squared test with Type I error=0.05) using intention-to-treat analysis, according to relative corticosteroid benefit when used as “rescue” therapy (horizontal axis) and to proportion of placebo arm subjects crossing over to “rescue” therapy (10% to 50%, as labeled on each curve). The risk of mortality among crossovers from placebo, if “rescue” therapy not given, is assumed to be 50%. Tx denotes treatment.